Found 67 clinical trials
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
Research Study For People With Chronic Hives
Pharmaceutical Research & Consulting, Inc. is conducting a research study with an investigational medication for adolescents with chronic hives. If you are 12 years to 17 years old and have
- 2336 views
- 21 Jan, 2021
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A research study for those suffering with chronic hives despite treatment with an antihistamine.
The purpose of this study is to evaluate the safety and effectiveness of an investigational oral medication for the treatment of hives. This study includes 7 clinical visits over
- 177 views
- 26 Sep, 2019
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting Seniors
-
Currently Recruiting
An investigational biologic medication for the treatment of uncontrolled hives despite antihistamine use.
5 Clinic visits over 40 weeks testing a self injected investigational medication versus placebo for the treatment of uncontrolled hives despite antihistamines. You will
- 29 views
- 23 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Dermatology
-
Currently Recruiting
Allergic Contact Dermatitis Study for 18 years and older
Have you been suffering with Allergic Contact Dermatitis (skin rash, hives, etc.) We have a new trial opening for adults who have been diagnosed with moderate to severe Allergic Contact Dermatitis
- 124 views
- 05 Jun, 2020
- 1 location
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Dermatology
-
Currently Recruiting
Allergic Contact Dermatitis study for 12-54 years of age
Have you been suffering with Allergic Contact Dermatitis (skin rash, hives, etc.) We have a new trial opening for children and adults who have been diagnosed with moderate to severe Allergic
- 273 views
- 05 Jun, 2020
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Cholinergic Urticaria - Efficacy of Dupilumab
The purpose of this study is to assess the efficacy in reducing disease activity and safety of Dupilumab in adult patients with cholinergic urticarial (CholU) who are symptomatic despite H1
- 52 views
- 23 Jan, 2021
- 3 locations
-
Phase 4 trial
-
Accepting pediatric ages
-
Accepting Seniors
-
10s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
Objective: To compare the efficacy of desloratadine 5mg (Denosin®) and levocetirizine 5mg (Xyzal®) once daily in the treatment of patients with CIU over 6 weeks. Trial design: Randomized, Double-Blind, Active-Controlled, Parallel-Group Study. Primary end point: To evaluate the change in average AM/PM reflective pruritus score from baseline recorded in the …
- 377 views
- 07 Nov, 2020
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting Seniors
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
Primary Objective: To demonstrate the efficacy of dupilumab in adult and adolescent participants with primary acquired chronic inducible cold urticaria (ColdU) who remain symptomatic
- 0 views
- 27 Jan, 2021
- 3 locations
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser
Cutaneous mastocytosis can be isolated or associated with systemic involvement. Urticaria pigmentosa affects around 80 to 85% of adult patients with cutaneous mastocytosis. It is also frequently
- 0 views
- 25 Jan, 2021
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
Background Mast cells help the body fight disease and heal wounds. People with indolent systemic mastocytosis (ISM) make too many mast cells. This causes pain, tiredness, digestive problems, and other symptoms. Researchers think the drug sarilumab could help. Objective To see if sarilumab is a safe and effective treatment for …
- 8 views
- 26 Jan, 2021
- 1 location